Stephan M. Feller
Cell Signalling Group
Molecular Oncology Laboratory
Cancer Research UK
Weatherall Institute of Molecular Medicine
UK
Name/email consistency: high
- High affinity molecules disrupting GRB2 protein complexes as a therapeutic strategy for chronic myelogenous leukaemia. Feller, S.M., Tuchscherer, G., Voss, J. Leuk. Lymphoma (2003)